Longitudinal Validation of the Cutaneous Lupus Erythematosus Quality of Life Index
Clicks: 3
ID: 330714
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
0.6
/100
3 views
2 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #366 of 371 articles by views in the british journal of dermatology
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 371 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
This study evaluated the Cutaneous Lupus Erythematosus (CLE) Quality of Life index (CLEQoL) as a valid, accurate, and longitudinally responsive patient reported outcome measure amongst CLE patients. Results show that the CLEQoL accurately captures QoL impacts amongst CLE patients and tracks changes in QoL impacts across time and disease activity.
| Reference Key |
openalex_W7214985500
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Vraj K Shah, Elena Wei, Stephen Neely, Motolani E. Ogunsanya, Victoria P. Werth, Benjamin F. Chong |
| Journal | the british journal of dermatology |
| Year | 2026 |
| DOI |
10.1093/bjd/ljag432
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.